For the year ending 2025-12-31, NGNE has $288,604K in assets. $23,717K in debts. $103,845K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 103,845 | |||
| Short-term investments | 165,168 | |||
| Prepaid expenses and other current assets | 2,757 | |||
| Total current assets | 271,770 | |||
| Property and equipment, net | 12,792 | |||
| Operating lease right-of-use assets | 2,648 | |||
| Finance lease right-of-use assets | 22 | |||
| Restricted cash | 339 | |||
| Other non-current assets | 1,033 | |||
| Total assets | 288,604 | |||
| Accounts payable | 1,953 | |||
| Accrued expenses and other current liabilities | 10,756 | |||
| Operating lease liabilities, current | 3,050 | |||
| Finance lease liabilities, current | 14 | |||
| Contingent value rights liability, current | 638 | |||
| Total current liabilities | 16,411 | |||
| Operating lease liabilities, non-current | 6,822 | |||
| Finance lease liabilities, non-current | 5 | |||
| Contingent value rights liability, non-current | 428 | |||
| Other liabilities | 51 | |||
| Total liabilities | 23,717 | |||
| Additional paid-in capital | 617,536 | |||
| Accumulated deficit | -352,649 | |||
| Total stockholders' equity | 264,887 | |||
| Total liabilities and stockholders' equity | 288,604 | |||
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)